Bellus Stock Today

BLU -  USA Stock  

USD 8.28  0.65  8.52%

Market Performance
6 of 100
Odds Of Distress
Less than 45
Bellus Health is selling for under 8.28 as of the 27th of May 2022; that is 8.52 percent increase since the beginning of the trading day. The stock's last reported lowest price was 7.57. Bellus Health has 45 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Bellus Health are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of April 2022 and ending today, the 27th of May 2022. Please note, there could be an existing legal relationship between Bellus Health (BLU) and BELLUS HEALTH INC (BLUSF). Click here to learn more.
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough and other cough hypersensitivity indications. The company was incorporated in 1993 and is based in Laval, Canada. Bellus Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 103.35 M outstanding shares of which 11.47 M shares are currently shorted by investors with about 13.81 days to cover. More on Bellus Health

Bellus Health Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Bellus Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bellus Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Bellus Health has very high historical volatility over the last 90 days
The company reported the last year's revenue of 16 K. Reported Net Loss for the year was (71.22 M) with profit before taxes, overhead, and interest of 16 K.
Bellus Health has about 248.81 M in cash with (61.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.34.
Bellus Health has a frail financial position based on the latest SEC disclosures
Over 89.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.fool.ca: Is Bellus Health Stock Still a Buy After 30 percent Earnings Jump - The Motley Fool Canada
Bellus Health Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Bellus Health SEC Filings
Bellus Health SEC Filings Security & Exchange Commission EDGAR Reports
Related EntityBLUSF (BELLUS HEALTH INC)
Joint CEO, Executive DirectorMark Levy  (View All)
Thematic Classification
Currently Active Investing Idea (view all)
Pharmaceutical Products
Average Analyst Recommendation
Analysts covering Bellus Health report their recommendations after researching Bellus Health's financial statements, talking to executives and customers, or listening in on Bellus Health's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Bellus Health. The Bellus consensus assessment is calculated by taking the average forecast from all of the analysts covering Bellus Health.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Bellus Health based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Bellus Health financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 3 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares63.8 M78.3 M
Significantly Down
Increasing
Slightly volatile
Total Assets334 M309.6 M
Significantly Up
Increasing
Slightly volatile
Total Liabilities6.4 M6.9 M
Significantly Down
Increasing
Slightly volatile
Current Assets278.6 M258.2 M
Significantly Up
Increasing
Slightly volatile
Current Liabilities18.3 M16.9 M
Significantly Up
Increasing
Slightly volatile
Total Debt939.8 K871 K
Significantly Up
Increasing
Slightly volatile
Gross Margin0.890.9
Fairly Down
Decreasing
Slightly volatile
Asset Turnover9.0E-49.0E-4
Slightly Down
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Bellus Health's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Bellus Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Bellus Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Bellus Health's financial leverage. It provides some insight into what part of Bellus Health's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Bellus Health's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Bellus Health deploys its capital and how much of that capital is borrowed.
Liquidity
Bellus Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 871 K in debt with debt to equity (D/E) ratio of 0.0, which may show that the company is not taking advantage of profits from borrowing. Bellus Health has a current ratio of 14.93, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Bellus Health until it has trouble settling it off, either with new capital or with free cash flow. So, Bellus Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bellus Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bellus to invest in growth at high rates of return. When we think about Bellus Health's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(62.83 Million)Share
Bellus Health (BLU) is traded on NASDAQ Exchange in USA. It is located in 275 Armand-Frappier Boulevard and employs 40 people. Bellus Health is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with total capitalization of 853.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bellus Health's market, we take the total number of its shares issued and multiply it by Bellus Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Bellus Health runs under Healthcare sector within Biotechnology industry. The entity has 103.35 M outstanding shares of which 11.47 M shares are currently shorted by investors with about 13.81 days to cover. Bellus Health has about 248.81 M in cash with (61.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.34.
Check Bellus Health Probability Of Bankruptcy
Ownership
Bellus Health retains a total of 103.35 Million outstanding shares. The majority of Bellus Health outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Bellus Health to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Bellus Health. Please pay attention to any change in the institutional holdings of Bellus Health as this could imply that something significant has changed or about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.

Ownership Allocation (%)

Check Bellus Ownership Details

Bellus Stock Price Odds Analysis

What are Bellus Health's target price odds to finish over the current price? Attributed to a normal probability distribution, the odds of Bellus Health jumping above the current price in 90 days from now is about 18.88%. The Bellus Health probability density function shows the probability of Bellus Health stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.3205 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Bellus Health will likely underperform. Additionally, the company has an alpha of 0.587, implying that it can generate a 0.59 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 8.28HorizonTargetOdds Above 8.28
81.04%90 days
 8.28 
18.88%
Based on a normal probability distribution, the odds of Bellus Health to move above the current price in 90 days from now is about 18.88 (This Bellus Health probability density function shows the probability of Bellus Stock to fall within a particular range of prices over 90 days) .

Bellus Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Bellus Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Bellus Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Bellus Health's value.
InstituionSecurity TypeTotal SharesValue
Ra Capital Management LpCommon Shares10.2 M70.4 M
Artal Group SaCommon Shares8.5 M58.5 M
View Bellus Health Diagnostics

Bellus Health Historical Income Statement

Bellus Health Income Statement is one of the three primary financial statements used for reporting Bellus's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Bellus Health revenue and expense. Bellus Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Bellus Health Gross Profit is comparatively stable at the moment as compared to the past year. Bellus Health reported Gross Profit of 16,000 in 2021. Interest Expense is likely to gain to about 56.4 K in 2022, whereas Net Income is likely to drop (73.1 M) in 2022. View More Fundamentals

Bellus Stock Against Markets

Picking the right benchmark for Bellus Health stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Bellus Health stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Bellus Health is critical whether you are bullish or bearish towards Bellus Health at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bellus Health without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Pattern Recognition Now

   

Pattern Recognition

Use different Pattern Recognition models to time the market across multiple global exchanges
All  Next Launch Module

Bellus Health Corporate Directors

Bellus Health corporate directors refer to members of a Bellus Health board of directors. The board of directors generally takes responsibility for the Bellus Health's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Bellus Health's board members must vote for the resolution. The Bellus Health board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Mahtani Bhagwandas - Independent Non-Executive DirectorProfile
Jerry Vilakazi - Non-Executive Independent DirectorProfile
Gary Harlow - Independent Non-Executive DirectorProfile
Dean Suntup - Financial Director, DirectorProfile

Investing Bellus Health

You need to understand the risk of investing before taking a position in Bellus Health. The danger of trading Bellus Health is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Bellus Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Bellus Health. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Bellus Health is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Bellus Health information on this page should be used as a complementary analysis to other Bellus Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Bellus Stock analysis

When running Bellus Health price analysis, check to measure Bellus Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bellus Health is operating at the current time. Most of Bellus Health's value examination focuses on studying past and present price action to predict the probability of Bellus Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bellus Health's price. Additionally, you may evaluate how the addition of Bellus Health to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Transaction History
View history of all your transactions and understand their impact on performance
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Is Bellus Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bellus Health. If investors know Bellus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bellus Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bellus Health is measured differently than its book value, which is the value of Bellus that is recorded on the company's balance sheet. Investors also form their own opinion of Bellus Health's value that differs from its market value or its book value, called intrinsic value, which is Bellus Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bellus Health's market value can be influenced by many factors that don't directly affect Bellus Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bellus Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bellus Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bellus Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.